| Companies sponsors |
Argenx (efgartigimod) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| |
Welsh Government |
| Patient carer groups |
Muscular Dystrophy UK |
| |
Myaware |
| Professional groups |
British Society for Clinical Neurophysiology |
| |
Royal College of Physicians |
| |
UK Clinical Pharmacy Association |
| Comparator companies |
Accord UK (azathioprine, methotrexate, mycophenolate mofetil) – confidentiality agreement not signed, not participating |
| |
Advanz pharma (methotrexate) – confidentiality agreement not signed, not participating |
| |
Alliance pharmaceuticals (neostigmine) – confidentiality agreement not signed, not participating |
| |
Aspen (azathioprine) – confidentiality agreement not signed, not participating |
| |
Bio Products Laboratory (plasma exchange) – confidentiality agreement not signed, not participating |
| |
Biotest UK (plasma exchange) – confidentiality agreement not signed, not participating |
| |
Cipla EU (methotrexate) – confidentiality agreement not signed, not participating |
| |
CSL Behring UK (human immunoglobulin, plasma exchange) – confidentiality agreement not signed, not participating |
| |
Dexcel Pharma (ciclosporin) – confidentiality agreement not signed, not participating |
| |
Ennogen Pharma (azathioprine) – confidentiality agreement not signed, not participating |
| |
Grifols UK (human immunoglobulin, plasma exchange) – confidentiality agreement not signed, not participating |
| |
Healthcare pharma (azathioprine) – confidentiality agreement not signed, not participating |
| |
Hospira UK (methotrexate) – confidentiality agreement not signed, not participating |
| |
Medac GmBH (methotrexate) – confidentiality agreement not signed, not participating |
| |
Mylan (azathioprine, ciclosporin, pyridostigmine) – confidentiality agreement not signed, not participating |
| |
Napp Pharmaceutical (rituximab) – confidentiality agreement not signed, not participating |
| |
Nordic Pharma (methotrexate) – confidentiality agreement not signed, not participating |
| |
Nova laboratories (azathioprine) – confidentiality agreement not signed, not participating |
| |
Novartis (ciclosporin, mycophenolate mofetil) |
| |
Octapharma (plasma exchange) – confidentiality agreement not signed, not participating |
| |
Orion Pharma (methotrexate) – confidentiality agreement not signed, not participating |
| |
Pfizer (methotrexate, rituximab) – confidentiality agreement not signed, not participating |
| |
Roche (mycophenolate mofetil, rituximab) – confidentiality agreement not signed, not participating |
| |
Sandoz (methotrexate, mycophenolate mofetil, rituximab) – confidentiality agreement not signed, not participating |
| |
Teva UK (mycophenolate mofetil, plasma exchange) – confidentiality agreement not signed, not participating |
| |
Tillomed laboratories (azathioprine, mycophenolate mofetil) – confidentiality agreement not signed, not participating |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare Products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
National Institute for Health Research |